BusinessTeneobio and Poseida Announce License Agreement for the Use of UniDab™ in CAR T-Cell TherapyBy Nasdaq OMXMay 22, 2017, 12:02 PM UTC
BusinessAdaptimmune Announces Initiation of Myxoid/Round Cell Liposarcoma StudyBy Nasdaq OMXDec 5, 2016, 12:30 PM UTC
BusinessAdaptimmune Announces Collaboration with MSD to Evaluate KEYTRUDA® (pembrolizumab) in Combination with NY-ESO SPEAR® T-Cell Therapy in Multiple MyelomaBy Nasdaq OMXOct 27, 2016, 2:05 PM UTC
BusinessSelecta Biosciences Presented Preclinical Data Applying SVP-Rapamycin in Gene Therapy at Annual Congress of the European Society of Gene and Cell TherapyBy Nasdaq OMXOct 20, 2016, 12:01 PM UTC
BusinessSelecta Biosciences Presented Preclinical Data Applying SVP-Rapamycin in Gene Therapy at Annual Congress of the European Society of Gene and Cell TherapyBy Nasdaq OMXOct 20, 2016, 12:01 PM UTC
BusinessAdaptimmune Announces Initiation of Triple Tumor Study to Evaluate its SPEAR® T-Cell Therapy Targeting MAGE-A10By Nasdaq OMXOct 18, 2016, 12:00 PM UTC
BusinessAdaptimmune Provides Update on Clinical Study Evaluating its SPEAR® T-Cell Therapy Targeting NY-ESO-1 in Ovarian CancerBy Nasdaq OMXOct 12, 2016, 1:15 PM UTC
BusinessAdaptimmune Announces Strategic Manufacturing Agreement with PCT to Support Development of SPEAR® T-cell Therapies Towards CommercializationBy Nasdaq OMXSep 19, 2016, 11:30 AM UTC
